Background: Megaesophagus (ME) carries a poor long-term prognosis in dogs. In people, lower esophageal sphincter (LES) disorders causing functional obstruction are rare causes of ME that may respond to targeted treatment. Functional LES disorders are reported rarely in dogs because of challenges in diagnostic methodologies.
| INTRODUCTION
Megaesophagus (ME) in dogs is a motility disorder of the esophagus carrying a poor long-term prognosis with death frequently reported secondary to aspiration pneumonia, malnutrition, and euthanasia because of poor quality of life. [1] [2] [3] Classically, ME is described as congenital or acquired and as idiopathic or secondary to a number of underlying etiologies including hypoadrenocortisolism and myasthenia gravis (MG). [4] [5] [6] However, identification of an underlying disease fails to determine if a functional outflow obstruction of the esophagus is causing ME. This distinction is critically important in people where lower esophageal sphincter (LES) disorders causing functional obstruction (LES achalasia) are rare causes of ME that respond to targeted treatment designed to address esophagogastric outflow obstruction. [7] [8] [9] This condition is considered distinct from conditions that cause esophageal hypomotility without functional LES obstruction. Achalasia, a primary esophageal motility disorder in people, results from a selective loss of inhibitory myenteric neurons leading to failure of the LES to relax in response to a pharyngeal swallow and impaired esophageal peristalsis. 10 Although sporadic cases of functional LES obstruction have been suspected in dogs, comparable etiologic information is lacking. Functional LES disorders in dogs rarely are diagnosed because of limitations in currently available testing used in dysphagia evaluation. [11] [12] [13] [14] However, functional LES disorders may represent an important, yet undetected, subpopulation of dogs with ME, perhaps responsive to targeted intervention and with a different longterm prognosis.
In people, high-resolution manometry (HRM) is considered the gold standard for the diagnosis of functional LES disorders such as LES achalasia. Understanding the limitations of HRM in dogs, which include cost, availability, and animal compliance, our goal was to use a free-feeding VFSS protocol 15 to characterize VFSS features of functional LES obstruction. We defined a functional LES obstruction as failure of the LES to relax in response to a pharyngeal swallow.
Although a direct comparison between dogs and people cannot be made without manometry, we elected to refer to functional LES obstruction in our canine patients as LES achalasia-like syndrome (LES-AS) after the key pathophysiologic feature of achalasia in humans. 7, 16 Our objective was to identify VFSS parameters that could be used to identify LES-AS in dogs. We hypothesized that dogs with LES-AS could be distinguished from normal dogs using standardized VFSS criteria.
| MATERIALS AND METHODS

| Case selection and criteria
Medical records for dogs presented to the University of Missouri Veterinary Health Center (MU-VHC) between April 2015 and December 2017 for VFSS were retrospectively reviewed. Dogs were included if they had a standing, free-feeding VFSS available for review, a complete medical record, and evidence of failure of the LES to relax in response to a pharyngeal swallow (LES-AS). Dogs determined to have LES-AS, were further evaluated for discriminating criteria between LES-AS, dogs with non-LES-AS ME, and healthy dogs. Common features among dogs with LES-AS were assessed to evaluate for discrete clinical syndromes. 7, 17 Standardized assessment and diagnostic criteria were developed and validated by calculating agreement between a panel of investigators at the University of Missouri College of Veterinary Medicine and a blinded expert reviewer with expertise in the area of swallowing disorders (C.P.G.) based on diagnostic criteria and characteristic features of disease identified in people. These criteria included failure of the LES to relax in response to a pharyngeal swallow, esophageal motility, retained ingesta, or oral secretions within the esophagus, "bird beak," reflux, and the absence of mechanical obstruction. 7, 9, 18, 19 Objective metrics for determining ME involve comparisons to the cervical vertebrae or thoracic inlet. Unfortunately, these regions may be out of view during parts of the VFSS. As such, subjective assessment of dogs with all dogs with ME on VFSS was objectively evaluated by comparing the ratios of distal esophageal diameter (DeD) to the height of the 12th thoracic vertebral body compared to healthy dogs. For those with focal ME, the most distal portion of the esophagus orad to the obstruction was used to calculate the DeD.
Dogs receiving prokinetic medications or opioids and those with
focal ME or VFSS evidence of mechanical obstruction (including hiatal hernia and esophageal strictures) were excluded. Additional testing for hypothyroidism, MG, and hypoadrenocorticism was performed in most dogs at the discretion of the attending clinician based on supporting clinical evidence. Dogs with a positive diagnosis of hypothyroidism, MG, or hypoadrenocorticism were not excluded from further evaluation. Swallow studies were compared against archived normal data from a previous publication (n = 20). 15 Control dogs were considered healthy based on physical examination and the absence of either respiratory or gastrointestinal signs, including oral, pharyngeal, and esophageal dysphagia, for the 6 months before the VFSS.
| Demographic data
Demographic data, clinical features, duration of clinical signs, incidences of aspiration pneumonia, and body condition scores were acquired from the medical record.
| Videofluoroscopic swallow study protocol
The VFSS was performed in accordance with a previously validated free-feeding VFSS protocol. 15 
| Statistical analysis
Statistical analysis was performed using the MedCalc data analysis software (version 18.5). Descriptive statistics were determined where appropriate. Nonparametric analysis was performed on objective swallow metrics because of the small sample size. Data are presented as median and interquartile range (IQR). A 95% confidence interval (CI) was calculated for common VFSS features of LES-AS. A receiver operator characteristic curve analysis was performed to determine the sensitivity and specificity for detection of ME using a ratio between the maximal DeD and the height of the T12 vertebral body. Kappa or weighted kappa coefficients were calculated to assess for agreement between the MU panel and the independent reviewer (C.P.G.) for criteria discriminating between dogs with LES-AS and normal dogs and the assigned LES-AS subtype for each dog. Weighted kappa coefficients were weighed linearly. A P-value ≤.05 was considered significant.
| RESULTS
| Animals
One hundred thirty dogs underwent VFSS at the MU-VHC between April 2015 and December 2017. Twenty-nine dogs were found to have ME based on VFSS. Megaesophagus was described as either generalized (n = 23) or focal (n = 6). Those with generalized ME without LES-AS (n = 9) were characterized by diffuse esophageal body hypomotility without LES obstruction. In these cases, a food bolus passed unimpeded into the stomach once presented to the LES.
Timing of LES relaxation was coordinated with a pharyngeal swallow.
Videofluoroscopic swallow study diagnoses for the 130 cases reviewed are available in Figure 5 .
Of 130 VFSS, 19 dogs, including 61% of those with generalized ME, met entry criteria for further evaluation by having a failure of the LES to relax in response to pharyngeal swallow. For those with LES-AS, ages ranged from 5 weeks to 12 years, with a median (IQR) age of 2.5 years (0.9-6.7 years). Seven dogs were spayed females, 2 were intact females, 8 were castrated males, and 2 were intact males.
Breeds represented included mixed breeds (n = 4), Australian Shepherd (n = 3), Chihuahua (n = 2), Golden Retriever (n = 2), Miniature Schnauzer (n = 1), Miniature Dachshund (n = 1), Doberman Pinscher (n = 1), German Shepherd Dog (n = 1), Irish Wolfhound (n = 1), Boston Terrier (n = 1), German Shorthair Pointer (n = 1), and English Cocker Spaniel (n = 1). The median (IQR) body condition score on a 9-point scale was 3 (2-5), with 4-5 of 9 being considered ideal. 
| Videofluoroscopic swallow studies
| MU results
The VFSS metrics for evaluation are described in Table 2 . independently reviewed each study using the standardized criteria in features were not present in any dog with ME that did not also have LES-AS. Additional discriminatory VFSS criteria for LES-AS compared to controls are presented in Table 3 . Abnormal LES relaxation (failure to relax in response to pharyngeal swallowing) was observed in response to all food and liquid types, resulting in minimal gastric filling.
Type 2 LES-AS (n = 7 dogs) was characterized by hypomotile primary peristalsis with or without ME. Of note, increased hydrostatic pressure (achieved by sitting, upright feeding, or substantial accumulation of food within the esophagus) facilitated gastric filling.
Type 3 LES-AS (n = 3 dogs) was characterized by a spastic distal third of the esophagus or a hypermotile distal esophagus against a closed LES, with or without ME.
Pseudoachalasia (n = 1) was characterized by mechanical esophagealgastric junction outflow obstruction. In the dog in this report, it was caused by a circumferential adenocarcinoma.
Objective (DeD:T12) and subjective interpretations of ME were found to have perfect agreement. After agreement was achieved among the MU panel, discriminatory and subclassification criteria were compared to the review performed by the MD gastroenterologist to calculate agreement. Specific kappa values, standard error, and 95% CI are presented in Table 4 .
| DISCUSSION
Our study indicated that a subpopulation of dogs with ME has a func- The criterion standard for evaluation of LES achalasia in people is HRM, which evaluates esophageal motor function by detecting esophageal and LES pressure profiles. [7] [8] [9] 22 In humans, this technique allows detection and subcategorization of obstructive LES disorders based on their pathophysiologic profiles. 8 This technique rarely is utilized in companion animals because of limited availability, high cost, and variable animal tolerance. [23] [24] [25] Conventionally, evaluation of dysphagia in dogs has relied upon historical information, physical examination findings, and radiography including VFSS, all of which are considered the gold standard in veterinary medicine. 15 In people, swallow studies were used before the development of HRM to detect LES achalasia and more recently have been proposed as the method of choice for detecting recurrence of functional LES obstruction after treatment. 9, 18, 21 The barium esophagram is an established protocol for detecting LES achalasia and is considered an alternative initial approach in humans where LES achalasia is suspected. 7, 9, 21 Standardized dynamic contrast studies, such as the "timed barium swallow," allow clinicians to detect the extent of esophageal bolus retention. 18 Despite only moderate sensitivity, these tests are considered specific for a diagnosis of LES achalasia. 21 Before our VFSS-based study, there had been no such standardized protocols developed for evaluating functional LES obstruction in dogs.
In part, this may be a consequence of the paucity of VFSS in dogs with ME and other forms of dysphagia, for which the historical protocol of restrained recumbency and force feeding of contrast has unacceptable risks of aspiration. 26, 27 However, allowing upright free-feeding in unrestrained dogs dramatically decreases the risk of aspiration to no more than what would be encountered during feeding at home and allows the study of any type of dysphagia (ie, oral, pharyngeal, or esophageal). 15 This technique also allows the investigator to assess the timing of LES relaxation in response to a pharyngeal swallow, allowing investigators to distinguish between LES-AS and other forms of ME. These are broadly characterized by esophageal hypomotility or weakness without functional obstruction of the LES. This distinction is critically important because the functional obstruction at the level of the LES is what determines candidacy for targeted therapeutic intervention. In our clinic, no dog having undergone a free-feeding VFSS that developed postprocedural aspiration pneumonia. Our VFSS findings can be contrasted to those of a prior study where VFSS performed with dogs in lateral recumbency failed to identify any dog with functional LES obstruction compared to 61% of our patients with ME ( Figure 5 ). 27 Our findings suggest that this procedure can be performed safely in dogs with ME and esophageal dysphagia to identify dogs with functional LES disorders.
Abnormal relaxation of the LES in response to pharyngeal swallowing is recognized as the key pathophysiologic feature in LES achalasia. [7] [8] [9] 22 This highlights the need for evaluation of the LES during active swallowing in order to assess for inappropriate failure of the LES to relax. Several swallows should be evaluated for each food and liquid consistency, because LES achalasia may not occur with every swallow.
Common features of LES achalasia in people undergoing dynamic imaging include ME, LES "bird beak," lack of primary peristalsis, and a persistent contrast column above the LES. 9 As a result of this functional obstruction, the esophageal body can lose tone and dilate, retaining both ingesta and oral or respiratory secretions. In our study, these clinical features also were identified in dogs with LES-AS. Interestingly, though ME commonly was identified, 5 of 19 dogs with LES-AS had objectively and subjectively normal esophageal diameter compared to controls. As such, the absence of ME does not rule out LES-AS in dogs and should be considered as a differential diagnosis in dogs with signs of esophageal dysphagia despite the absence of ME. Serial evaluation of these dogs would be warranted to determine if they progress to development of ME. In our study, subjective and objective assessment of ME in dogs compared to healthy dogs had perfect agreement, suggesting that objective calculations are not always necessary to confirm a diagnosis of ME and objective measurement may be reserved for cases in which ME may be considered borderline. However, the lack of a gold standard measurement for ME is a limitation in calculating specificity for dogs in our study. A baseline fluid line and "bird beak" frequently were identified in patients with LES-AS and were absent in normal dogs and in this population of dogs with other forms of ME. This observation may suggest that fluid line and "bird beak" could discriminate LES-AS from forms ME, but further study is needed. Two cases of confirmed MG were identified in our population: 1 with LES-AS and the other with diffuse esophageal hypomotility without LES obstruction. A previously published case report performed manometry to confirm functional LES obstruction in a Pug with seronegative MG. 24 This suggests that functional obstruction of the LES may be a feature of ME in some, but not all patients with MG. However, too little data exists to speculate on the pathophysiology of ME in these patients.
In humans, LES achalasia represents a family of syndromes grouped by variations in esophageal contractility rather than a single disorder characterized by a sole discrete phenotype. [7] [8] [9] The subtype of LES-AS in people does not determine candidacy for targeted intervention.
It may, however, be used to help determine which means of LES disruption is selected (eg, pneumatic dilatation versus botulinum toxin A injections or surgery) because different subtypes may have different response rates. 8, 16, 17, 22 Three phenotypes were characterized in our canine animal population, which share similarities to the syndromes described in people. [7] [8] [9] As in people, type 1 was considered end-stage with the absence of esophageal motility and the presence of esophageal dilatation and minimal gastric filling. Given the clinical importance of ME and esophageal dysphagia in dogs, it is critical that patients that may be responsive to targeted treatment be accurately identified. For this reason, VFSS images were interpreted by a blinded, independent MD reviewer who participated in the international working group for disorders of gastrointestinal motility and function to develop the consensus statement on achalasia syndromes in humans. Our goal was to adapt these diagnostic criteria and gauge the ease by which they could be applied to clinically affected dogs. 16 Agreement between the MU group and the MD reviewer was perfect for 6 of 17 VFSS parameters, nearly perfect for 5 of 17 parameters, substantial for 4 of 17 parameters, moderate for 1 of 17 parameters, and fair for 1 of 17 parameters 29 (Table 4 ). These findings suggest that, with training, these criteria could be applied by others to detect the subpopulation of dogs affected by LES-AS, thus enhancing the ability of veterinarians to detect patients that may respond to targeted intervention. Only fair agreement, however, was reached for the frequency of abnormal swallow events (ie, failure of the LES to relax in response to pharyngeal swallow). This finding supports our earlier recommendation that multiple swallow events should be evaluated because, depending on the LES-AS subtype and observer, aberrant swallowing events may appear variably frequent. However, this did not impact the agreement between the MU panel and the independent reviewer (C.P.G.) for the final diagnosis of LES-AS for any dog.
| CONCLUSIONS
Because of its inherent limitations, HRM for diagnosis of LES-AS does not currently have substantial clinical utility outside a few veterinary research centers or tertiary care facilities. The morbidity and mortality of ME in dogs necessitated developing a more accessible diagnostic test for identifying dogs that may respond to targeted intervention.
Compared to HRM, VFSS is relatively accessible, inexpensive, and, with training, easy to perform. In keeping with our stated objective, we demonstrated that functional LES obstructions (LES-AS) can be identified by VFSS. We also have demonstrated the VFSS could identify discrete achalasia syndromes as appreciated in humans. Interpretation will require high-quality diagnostic studies and practice, with the guidelines developed herein highlighting important features of LES-AS. Identifying this previously unrecognized animal population allows future exploration of treatments focusing on relieving functional obstruction of the LES to decrease morbidity and mortality associated with ME and esophageal dysphagia in dogs.
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